ClinicalTrials.gg
RecruitingNCT06447948KESSUpdated Jul 28, 2026

Keep Exercising & Stay Steady: Development and Feasibility of a Health Intervention to Encourage Exercise Maintenance After Fall Prevention Exercise Programmes End.

An interventional study of Keep Exercising and Stay Steady in Fall Patients, sponsored by Northumbria University. Recruiting at 4 sites in United Kingdom. Per ClinicalTrials.gov, last updated 2026-07-28.

Sponsored by Northumbria University · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Started Jun 2024; still recruiting 2 years 5 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Not applicable
Sex
All
01

Study summary

Falls and broken bones are a common health problem faced by older adults. Worldwide, one third of adults aged over 65 years old, and half of adults aged over 80 years, fall each year. One in five falls in older adults result in hospitalisation and one in twenty cause broken bones. Each year, 300,000 older adults break a bone following a fall which costs the UK £4.4billion in healthcare costs. Broken hip bones are the most serious outcome of a fall. One in twenty older adults will die and one in five need care assisted living following a hip fracture.

Muscles and bones become weaker after 50 years of age which increases an older adults' risk of falling and breaking a bone. Falls prevention programmes that include muscle strength and balance exercise improves physical function and helps to prevent falls and broken bones in older adults. However, many older adults stop doing exercise and become less physically active after falls prevention programmes end. Gains in balance and muscle strength are lost and falls risk increase if people don't keep exercising. More people are reaching older ages and becoming less active. Therefore, this problem will worsen unless healthcare practices become better at preventing falls and broken bones in older adults.

The research ambition is to create a peer supported home exercise programme that encourages older adults to keep exercising after falls prevention programmes end. This will help to prevent future falls and broken bones which will allow more older adults to continue living independently. The home exercise programme will benefit older adults everyday lives by helping them to maintain good physical health and improve their ability to perform daily tasks without the fear of falling.

Older people at risk of falls, clinicians, and public members will be invited to form a community of practice group. The group will work with the research team to create the home exercise programme. We will target the research to help older adults with the greatest health needs. Older adults living in deprived neighbourhoods have the greatest risk of falling and dying following a broken bone. The home exercise programme will be researched in older adults attending falls prevention programmes in the most deprived regions of England. This will help us to explore whether the programme could encourage the continuation of exercise in older adults who need it most.

Read the detailed description

PURPOSE:

Age-related declines in muscle strength and balance are key risk factors for falls and severe injury in older adults. Completion of group-based Falls Management Exercise (FaME) programmes, significantly improves muscle strength and balance, functional status and reduces falls incidence and injurious falls in older adults. Significant reductions in falls incidence are sustained for up to 2 years in people who maintain increases in their physical activity (PA) levels after FaME programmes end (IRR=0.49, 95% CI 0.30, 0.79; p=0.004). The proportion of people considered as being physically active is 54% upon exiting FaME programmes. However, these proportions decrease to between 40% to 49%, six to eighteen months after FaME programmes end.

Over time, improvements in strength, balance and physical function are lost and falls incidence increase if people do not remain active after programmes end. This research aims is to develop and investigate the feasibility and acceptability of a peer supported exercise maintenance intervention, that includes an NHS Approved Falls Prevention App (Keep on Keep Up (KOKU) App) and PA monitoring tools, to people exiting FaME programmes.

STUDY AIM: To design and investigate the feasibility, acceptability and safety of an exercise maintenance intervention to Falls Management Exercise (FaME) programme service-users.

STUDY OBJECTIVES:

  1. Co-design an exercise maintenance intervention with a Community of Practice Group (COPG). Professional Stakeholders and Patient and Public Involvement (PPI) members.
  2. Investigate the acceptability of the exercise maintenance intervention to FaME programme service-users.
  3. Assess the feasibility of the research methods and key parameters needed to conduct future clinical trials.

STUDY DESIGN: The project will be conducted in two separate phases as interdependency exists between the research objectives:

  • Phase 1. Intervention Development
  • Phase 2. Feasibility Study.

METHODS:

Phase 1. Intervention development

Intervention Development will be informed by the Normalisation Process Theory and Theoretical Framework of Acceptability[1, 2]. In a series of consultations, the investigators will work with groups of PPI members and key stakeholders (older adults, service providers, commissioners) to define an exercise maintenance intervention and procedures.

Consultations will be audio-recorded, transcribed, and analysed thematically to support the development of the exercise maintenance.

Phase 2. Feasibility Study:

A mixed methods single-arm multi-site feasibility study will be conducted to investigate the feasibility, acceptability and safety of the exercise maintenance intervention and the feasibility of the research methods.

The investigators will recruit and deliver the exercise maintenance intervention for up to 8 months in 30 FaME class attendees.

Feasibility data will be collected and measured over 8 months via:

  • Recruitment and retention rates.
  • Adverse event data
  • Intervention adherence will be ascertained via PASE scores measuring physical activity and strength and balance exercise.

    • Intervention acceptability will be examined via a tailored Health Intervention Acceptability Questionairre based on the Theoretical Framework of Acceptability

A priori progression criteria will be set on feasibility outcomes to determine future progression to a larger-scale clinical trial. The progression criteria for a full-scale trial will be as follows: ≥70% of targeted number of participants are recruited within a 6-month window; ≥50% of recruited participants complete the study and provide outcome data at follow up; evidence that participants have maintained an improvement in falls risk factors; \<10% of any serious adverse effects deemed to be due to the intervention.

Intervention acceptability will be qualitatively examined via semi-structured interviews with up to n=20 participants. Semi-structured interviews will be conducted by a researcher in the participants preferred venue or online. Interviews will be audio recorded, transcribed, and handled using NVIVO10-software. Two researchers will code the transcripts via framework analysis.

Participant data is routinely collected by the HealthWorks Charity for service purposes. Under information sharing agreements, the following routine data will be shared with the researchers: Age, gender, ethnicity, postcode/IMD, medical history, medication, falls history, functional ability (i.e. 30-s chair stand, Timed-Up-and-Go), balance measures (i.e. four-stage balance test).

Routine data on functional ability will be collected at three time-points (T1-before FaME, T2-after FaME, T3-after the maintenance intervention) and will be analysed and reported via descriptive statistics.

SAMPLE \& SETTING: The investigators are working in collaboration with the HealthWorks Charity that delivers FaME classes to people living in deprived areas of Newcastle Upon Tyne (England). To ensure people experiencing health inequalities are represented in the study, the investigators will recruit a sample of older adults from four HealthWorks Charity hubs and deliver the intervention in these venues.

02

Conditions studied

  • Fall Patients

Browse trials for

Keywords

  • Falls Prevention
  • Ageing Health
  • Physical activity
  • Exercise Maintenance
  • Behaviour Change
  • Digital health
  • Older Adults
03

In context

Motor Activity

9,798 studies on the registry are indexed under Motor Activity; 1,910 are open to participants now.

This study's planned enrollment of 30 is below the median of 60 across 8,388 interventional studies indexed under Motor Activity.

Browse Motor Activity studies →

Lead sponsor

Northumbria University is the lead sponsor of 160 studies on the registry; 22 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Eligibility criteria:

  • Community dwelling older adults
  • Enrolled on a Healthworks FaME programme in the Northeast region of England.
  • Able to provide informed written consent.

Exclusion criteria:

  • Unable to independently walk 5 metres with or without a walking aid.
  • Advised by a medic not to undertake exercise.
  • Has a medical, cognitive, or physical condition that prevents safe engagement with digital technology or unsupervised exercise.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Intervention

    Single Arm Feasibility Study: Study participants (n=30) will test the exercise maintenance intervention components for up to 9 months.

    Behavioral: Keep Exercising and Stay Steady

Interventions

  • BehavioralKeep Exercising and Stay Steady

    Eight KESS sessions will be delivered via a motivational interview approach, in face to face group sessions, delivered by postural stability instructors at the participants usual class venue. Guest speakers will deliver specialist education. Participants will receive text message reminders and telephone follow up for non attendance. Three KESS sessions will take place before programmes end with education and various behaviour change strategies being delivered to help participants develop an intention of continuing exercising/ being active when programmes end. Five sessions will take place over a 6 months duration when programmes end with behavior change strategies and education being delivered that aims to bridge the gap between behavioral intentions and actions to encourage the long-term continuation of good physical activity habits and continued social interactions.

    Also known as: KESS

06

What researchers measure

Primary outcomes

  1. Health Intervention Acceptability Questionnaire

    KESS intervention acceptability feedback will be collected via Health Intervention Acceptability Questionnaire. The questionnaire contains 14 questions and statements and asks respondents to rate their responses using a 1 to 5 sliding scale (i.e. 1= completely unacceptable - 5 = completely acceptable).

    Time frame: 8 months / after completion of the the KESS intervention

  2. Physical Activity Scale for the Elderly questionnaire (PASE)

    Intervention adherence will be ascertained via weekly PASE scores measuring physical activity and strength and balance exercise. The PASE questionnaire asks respondents to provide information on the amount of physical activity they have performed for leisure, household chores and work / occupational tasks in the past 7 days.

    Time frame: after 8 month of using the KESS intervention

Secondary outcomes

  1. Recruitment rates (phase 2)

    Recruitment rates will be recorded as the number of participants invited and the percentage consenting to enter the feasibility study.

    Time frame: after 8 month

  2. Retention rates (phase 2)

    Retention rates will be calculated as the percentage of class participants providing follow up data post intervention.

    Time frame: during and after 8 month of using the KESS intervention

  3. Adverse event data (Phase 2)

    Adverse event data will be collected by the research team monthly (via email and telephone) and assessed by the Principal Investigator and Clinical Leads for causality to determine if events are related to the interventions receipt.

    Time frame: during the 6 month intervention period after the inital falls prevention programme ends

  4. Semi-structured interviews regarding KESS Acceptability

    Intervention acceptability will be qualitatively examined via semi-structured interviews with up to n=20 participants. Interview Schedules will be informed by the Theoretical Framework of Acceptability and Seniors Technology Acceptance Model.

    Time frame: after the 8 month intervention period.

07

Study locations

4 of 4 sites recruiting
  • Healthworks, The Lemington Centre, Wallbottle
    Newcastle upon Tyne, Tyne and Wear NE15 8RZ, United Kingdom
    Recruiting
  • Healthworks, Trinity Church, Gosforth
    Newcastle upon Tyne, Tyne and Wear NE3 4AG, United Kingdom
    Recruiting
  • HealthWorks: The Health Resource Centre, Benwell
    Newcastle upon Tyne, Tyne and Wear NE4 8BE, United Kingdom
    Recruiting
  • Healthworks, East End Pool, Byker
    Newcastle upon Tyne, Tyne and Wear NE6 1AL, United Kingdom
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jun 2024 to primary completion in Apr 2026, 22 months.

Of 5,147 non-industry interventional studies with no phase under Motor Activity, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 36. This study's 22 months is above that.

Counting every sponsor, half of 5,207 studies reached it within 17 months; a quarter within 7 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
May 13, 2024
First posted
Jun 7, 2024
StartActual
Jun 1, 2024
Primary completionActual
Apr 1, 2026
CompletionEst.
Oct 19, 2026
Last update
Jul 28, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 28, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06447948
Collaborators
Orthopaedic Research UK, HealthWorks Newcastle Upon Tyne, KOKU Health CIC, The University of Manchester, Glasgow Caledonian University
Responsible party
Sponsor
First posted
Jun 7, 2024
Start date
Jun 1, 2024
Primary completion
Apr 1, 2026
Completion
Oct 19, 2026 (estimated)
Last update
Jul 28, 2026

Study contacts

Sarah Audsley, PhD
Contact
s.audsley@northumbria.ac.uk
+44 07951000075
Gill Barry, PhD
Contact
gill.barry@northumbria.ac.uk
+44 01912437635

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion